ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
132.07
0.00
(0.00%)
Closed December 06 4:00PM
0.00
0.00
(0.00%)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

ASND News

Official News Only

ASND Discussion

View Posts
Monksdream Monksdream 9 months ago
ASND new 52=week high
👍️0
Monksdream Monksdream 10 months ago
ASND new 52 week high
👍️0
MiamiGent MiamiGent 10 months ago
What goes down, must go up :)
Hope you banked, monk.
👍️0
Monksdream Monksdream 10 months ago
ASND new 52 week high
👍️0
Monksdream Monksdream 11 months ago
ASND new 52 week high
👍️0
MiamiGent MiamiGent 2 years ago
ASND 161 shares traded in pre-mkt. Take your profits- nobody going to hold up this dilution candidate.
Bearish
👍️0
MiamiGent MiamiGent 2 years ago
ASND After just one day of wooing, ASND is FALLING ...........in love with my short.
Irresistible attraction: fourteen-month delay on average, need for more money and a red market with housing assuring further rate increase.
Quote as of 5/02/2023 2:44PM ET
$86.375 -$0.365 (-0.421%)
Bearish
https://www.bing.com/videos/search?q=you+tube+music+roy+orbison+i%27m+falling&view=detail&mid=17436B40AE02F042D00317436B40AE02F042D003&FORM=VIRE
👍️0
MiamiGent MiamiGent 2 years ago
$ASND
A complete response letter (CRL) from the FDA delays a product’s entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them.
FDA NEWS
Bearish
👍️0
MiamiGent MiamiGent 2 years ago
ASND Net Income -$622,419,000 in 2022

Anyone want to venture a guess when the raise will come?

I'll take a WAG and say within two weeks.
👍️0
MiamiGent MiamiGent 2 years ago
ASND Quote as of 5/02/2023 10:14AM ET

$88.07 +$1.33 (+1.533%)

I'm down -3.22% on my short. Did not choose well- 100% owned by institutions.. not easily budged.
I am counting on red days, 3 day rule, CRL and outside chance of a raise- it's all I got, lol

https://stockcharts.com/h-sc/ui?s=ASND
👍️0
MiamiGent MiamiGent 2 years ago
Short today at 85.34

How long will this languish before possible good news?

Will need to raise more $$
👍️0
crudeoil24 crudeoil24 3 years ago
Ascendis Pharma: FDA Approves Skytrofa to Treat Pediatric Growth Hormone Deficiency > ASND
3:46 pm ET August 25, 2021

By Stephen Nakrosis

Ascendis Pharma A/S on Wednesday said the U.S. Food and Drug Administration approved its Skytrofa as a treatment for Pediatric Growth Hormone Deficiency.

The company said Skytrofa, or lonapegsomatropin-tcgd, is the first once-weekly treatment approved to treat Pediatric Growth Hormone Deficiency.

The company also said Skytrofa was approved to treat "pediatric patients one year and older who weigh at least 11.5 kg and have growth failure due to inadequate secretion of endogenous growth hormone."

The company said the approval includes its Skytrofa Auto-Injector and cartridges, which enable families to store the medicine at room temperature for up to six months.

The company said availability of Skytrofa in the U.S. is expected soon.

Ascendis said it would hold an investor conference call at 4:30 p.m. ET today.


Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
👍️0
crudeoil24 crudeoil24 3 years ago

ASCENDIS PHARMA A/S is a Danish-based biopharmaceutical company, which is involved in manufacture products for rare diseases. The Company utilizes its TransCon technologies for treatment, which can be applied to existing drug therapies, including proteins, peptides and small molecules, to create prodrugs. The Company is headquartered in Copenhagen, Denmark with offices in Heidelberg, Germany and Palo Alto, California.
👍️0

Your Recent History

Delayed Upgrade Clock